Oral Candidiasis
Mostrando 1-12 de 189 artigos, teses e dissertações.
-
1. Qual a conduta em caso de candidíase de repetição em idosas sem comorbidades?
A candidíase vulvovaginal recorrente (quatro ou mais episódios sintomáticos em um ano) afeta cerca de 5% das mulheres em idade reprodutiva, porém é menos prevalente em idosas, o que justificaria uma investigação mais aprofundada, sobretudo pensando em neoplasias
.
Mesmo que exista uma aparente ausência de comorbidades, deve-se buscar o
Núcleo de Telessaúde Espírito Santo. Publicado em: 12/06/2023
-
2. Quais os tratamentos disponíveis para candidíase vulvovaginal recorrente?
As terapias tópicas são indicadas para casos com sintomas leves a moderado, já as terapias orais são indicadas para sintomas graves e como manutenção para prevenir as recidivas. O tratamento da candidíase vulvovaginal recorrente (RVVC) envolve a terapia inicial de indução, com a utilização de azóis tópicos ou orais, seguida de terapia supress
Núcleo de Telessaúde Santa Catarina. Publicado em: 12/06/2023
-
3. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis
Revista da Associação Médica Brasileira. Publicado em: 2022
-
4. Virulence factors of Candida species from the oral mucosa and prostheses of elderly people from a riverside community in the Amazon state, Brazil
Resumo Introdução A Candida albicans é a levedura que mais acomete a cavidade oral, podendo causar infecção. Porém diversos fatores podem estar associados ao aparecimento da candidíase, que podem estar relacionados com a higiene e saúde dos indivíduos, mas também com a patogenicidade destes microrganismos. Objetivo Avaliar os fatores de virulênc
Rev. odontol. UNESP. Publicado em: 02/12/2019
-
5. Sensitivity to antifungals by Candida spp samples isolated from cases of chronic atrophic candidiasis (CAC)
Resumo O tratamento de escolha para candidíase atrófica crônica (CAC), também conhecida como estomatite protética, é a terapia antifúngica tópica. Este estudo teve como objetivo isolar, identificar e avaliar a susceptibilidade antifúngica de espécies de Candida de locais mucosos em portadores de prótese com diagnóstico de CAC e determinar a preva
Braz. J. Biol.. Publicado em: 04/07/2019
-
6. Anadenanthera Colubrina vell Brenan: anti-Candida and antibiofilm activities, toxicity and therapeutical action
Abstract: We evaluated the antifungal and antibiofilm potential of the hydroalcoholic extract of bark from Anadenanthera colubrina (vell.) Brenan, known as Angico, against Candida spp. Antifungal activity was evaluated using the microdilution technique through the Minimum Inhibitory and Fungicide Concentrations (MIC and MFC). The antibiofilm potential was te
Braz. oral res.. Publicado em: 04/04/2019
-
7. Avaliação da eficácia do fitoterápico a base de Cymbopogon citratus no tratamento da Candidose em usuários de prótese
Objective: To evaluate the effectiveness of the gel Cymbopogon citratus (DC.) Stapf (lemon grass) in the treatment of oral candidiasis in patients weares of prosthesis, comparing the results with Daktarin oral gel. To this end, we carried out a randomized, blinded, controlled. Methods: The sample consisted of 30 adult patients, volunteers of both sexes, who
Publicado em: 2019
-
8. A single-center 18-year experience with oral candidiasis in Brazil: a retrospective study of 1,534 cases
Abstract Despite the large number of published studies about oral candidiasis and associated risk factors, reports of large single-center retrospective studies on the prevalence of oral candidiasis, risk factors, and the oral candidiasis types diagnosed more frequently in oral diagnostic reference centers are scarce. The objective of the present study was to
Braz. oral res.. Publicado em: 17/09/2018
-
9. Presence of Candida spp. and candidiasis in liver transplant patients
Abstract: BACKGROUND: Candidiasis is the most common opportunistic fungal infection of the oral cavity caused by fungi of the genus Candida and usually associated with immunosuppressed individuals. OBJECTIVES: To evaluate the presence of oral candidiasis and identify the presence of Candida spp. in liver transplant recipients and assess the association bet
An. Bras. Dermatol.. Publicado em: 2018-06
-
10. Clinical and laboratorial features of oral candidiasis in HIV-positive patients
Abstract INTRODUCTION We describe the clinical and laboratorial features of oral candidiasis in 66 HIV-positive patients. METHODS: Polymerase chain reaction-based techniques were performed for differentiation of Candida spp. isolated from patients at a public teaching hospital in Midwest Brazil. RESULTS: Oral lesions, mainly pseudomembranous, were signif
Rev. Soc. Bras. Med. Trop.. Publicado em: 2018-06
-
11. New perspectives on the nutritional factors influencing growth rate of Candida albicans in diabetics. An in vitro study
BACKGROUND The link between Candida albicans and diabetes mellitus is well-acknowledged, but incompletely elucidated. OBJECTIVES The purpose of this study is to assess the growth rate of C. albicans (CA) in the presence of different concentrations of glucose and fructose, two of the main pathophysiologic and nutritionally relevant sugars in diabetic pati
Mem. Inst. Oswaldo Cruz. Publicado em: 2017-09
-
12. Oral Candida spp carriage and periodontal diseases in HIV-infected patients in Ribeirão Preto, Brazil
ABSTRACT The majority of HIV-infected patients develop Candida spp-associated clinical oral lesions. Studies have shown that asymptomatic oral colonization of Candida spp may lead to oral lesions or become a source of disseminated infections. The aim of this study was to verify the effects of periodontal conditions on Candida spp prevalence and Candida spp c
Rev. Inst. Med. trop. S. Paulo. Publicado em: 01/06/2017